Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Financings Routine +

Extendicare Announces Closing of $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes

Extendicare Closes Investment Grade Debt, Consolidating Growth Strategy

Executive Summary
  • Extendicare Inc. announced the closing of its inaugural $450 million offering of senior unsecured notes due April 14, 2031.
  • The notes carry a coupon rate of 4.345% and received a final BBB credit rating with a stable trend from Morningstar DBRS.
  • Proceeds were utilized primarily to repay the term credit facility in full ($427.7 million) and reduce the revolving credit facility.
  • All security previously granted to lenders has been released, converting the remaining revolver into senior unsecured debt ranking pari passu with the new notes.
  • This follows the pricing announcement on April 9, 2026, and the closing of the $570 million CBI Home Health acquisition on April 1, 2026.
  • The company continues to operate under a strategy focused on scale in home health care and long-term care facilities across Canada.
Material Impact
  • Classification: Routine - Positive. The financing was priced and announced on April 9; the closing is an execution of known terms rather than new market-moving information.
  • Capital Structure Improvement: The shift from secured to unsecured investment-grade debt (BBB) reduces refinancing risk and improves liquidity flexibility, which is a structural positive for the balance sheet.
  • Cost of Capital: At 4.345%, the cost is reasonable but not negligible given the high leverage context; however, it replaces higher-cost or secured debt obligations.
  • Market Expectation: The market had already priced in this financing and the acquisition synergies following the April 9 pricing announcement, evidenced by the stock trading near highs ($29.63) prior to closing.
  • Dividend Sustainability: Despite increased leverage (projected 3.3x debt/EBITDA), management announced a 5% dividend increase in February, signaling confidence but adding pressure on cash flow coverage.
EXE · Price
Company Overview
  • Company: Extendicare Inc., a Canadian healthcare company focused on long-term care (LTC) and home health services.
  • Flagship Project/Strategy: Expansion of the home health care platform through acquisitions, specifically the ParaMed subsidiary integrating with CBI Home Health.
  • Operational Metrics: Q4 2025 LTC occupancy at 98.0%; Home health ADV (Average Daily Volume) up 27.3% YoY to 39,440.
  • Geographic Footprint: Operations across seven provinces following the CBI acquisition, delivering over 10 million care hours annually.
Read the original news release →

More from EXTENDICARE INC.